Secukinumab Fails to Show Benefit in Graves' Orbitopathy

Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves’ orbitopathy, according to the ORBIT study.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/secukinumab-fails-show-benefit-graves-orbitopathy-2025a1000yyx?src=rss

Author :

Publish date : 2025-12-16 12:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Secukinumab Fails to Show Benefit in Graves’ Orbitopathy

Risk-Based Early-Term Birth Cuts Preeclampsia Risk

Do Fertility Treatments Raise Heart Disease Risks in Women?

Related Posts

Precision or Collateral Damage? Oncology’s F-16 Moment

Regular Physical Activity Thwarts Fatigue, Boosts QoL in Colorectal Cancer

The Berkshire mum looking to encourage others into rugby

Drinking Coffee May Help Improve Heart Health, Lower Diabetes Risk

What Do the New Dietary Guidelines Emphasize?

Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

Precision or Collateral Damage? Oncology’s F-16 Moment

Regular Physical Activity Thwarts Fatigue, Boosts QoL in Colorectal Cancer

The Berkshire mum looking to encourage others into rugby

Drinking Coffee May Help Improve Heart Health, Lower Diabetes Risk

What Do the New Dietary Guidelines Emphasize?

Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

Global Pain Levels; Tertiary Patents on FDA-Approved Drugs

The True Miracle of Ivermectin

Categories

Archives